In conclusion, the novel B1 berberine derivative effectively targets the ubiquitination and degradation of SCD, inhibiting monounsaturated fatty acid synthesis, increasing oxidative stress and lipid peroxidation, and inducing ferroptosis, which collectively suppresses tumor growth (Fig. 8J). The gene discussed is SCD; the disease is neoplasm.